Abstract 1466: Combination immunotherapy successfully control tumor growth in a transgenic mouse model

作者
Kue Peng Lim,Syafinaz Zainal,Natasha Zulaziz,Chai Phei Gan,San Jiun Chai,Bryan Kit Weng Lye,Chuan Wang,Ruhcha V. Sutavani,Christian H. Ottensmeier,Emma V. King,Gareth J. Thomas,Natalia Savelyeva,Sok Ching Cheong
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:79 (13_Supplement): 1466-1466
标识
DOI:10.1158/1538-7445.am2019-1466
摘要

Abstract The use of checkpoint inhibitor anti-PD1 has achieved significant clinical benefit, in recurrent and metastatic head and neck cancer patients, where the overall response rate is between 16-20%. The use of antigen-specific cancer vaccine to increase the level of cytotoxic T cells is believed to work synergistically with anti-PD1. In this study, we evaluated the efficacy of antigen-specific DNA vaccine when it’s used in combination with anti-PD1. The B6.Cg-Tg(HLA-A/H2-D)2Enge/J mice bearing established tumours overexpressing the tumour antigen were vaccinated either with anti-PD1, DNA vaccine or anti-PD1 in combination with DNA vaccine. Tumour volume was monitored and antigen-specific immune responses were evaluated at the endpoint. Our data demonstrated DNA vaccine induced antigen-specific immune responses and animals vaccinated with DNA vaccine harboured smaller tumour volume compared to controls. Significantly, animals that received DNA vaccine expressed consistently higher levels IFN-γ and resulted in the upregulation of PD1 compared to control animals. We then demonstrated mice vaccinated with both DNA vaccine and anti-PD1 had near to complete tumour control, indicating a synergistic effect of DNA vaccine with anti-PD1. Animals treated with DNA vaccine in combination with anti-PD1 also have better overall survival. Importantly, these animals showed increased antigen-specific responses by the ELISPOT assay. In summary, our data suggest antigen-specific DNA vaccine works synergistically with anti-PD1 and conferred an excellent tumour control; this opens up a new opportunity of combinatory immunotherapy that might benefit a wider population of patients in an antigen-specific manner. Citation Format: Kue Peng Lim, Syafinaz Zainal, Natasha Zulaziz, Chai Phei Gan, San Jiun Chai, Bryan Kit Weng Lye, Chuan Wang, Ruhcha V. Sutavani, Christian Ottensmeier, Emma King, Gareth Thomas, Natalia Savelyeva, Sok Ching Cheong. Combination immunotherapy successfully control tumor growth in a transgenic mouse model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1466.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
落叶发布了新的文献求助10
1秒前
YM发布了新的文献求助10
2秒前
mumu完成签到 ,获得积分10
2秒前
2秒前
Frank发布了新的文献求助10
3秒前
San发布了新的文献求助10
3秒前
英吉利25发布了新的文献求助10
5秒前
仁爱嫣完成签到,获得积分10
5秒前
嘞嘞累哦完成签到,获得积分10
6秒前
ding的应助被陈鸿超采纳,获得10
6秒前
ZRH发布了新的文献求助10
6秒前
jerry完成签到 ,获得积分10
7秒前
斤斤计较发布了新的文献求助10
8秒前
8秒前
8秒前
8秒前
Qingzhu完成签到,获得积分10
10秒前
何糖完成签到 ,获得积分10
10秒前
Maestro_S的应助被感动的樱桃采纳,获得10
10秒前
syvshc的应助被QINYUYU采纳,获得10
12秒前
FashionBoy的应助被likes采纳,获得10
12秒前
12秒前
研友_VZG7GZ的应助被yun采纳,获得30
13秒前
李小晴天完成签到,获得积分10
13秒前
13秒前
可爱玫瑰发布了新的文献求助10
14秒前
15秒前
CodeCraft的应助被dengdeng采纳,获得10
15秒前
Yebo完成签到 ,获得积分10
15秒前
希尔巴德发布了新的文献求助10
15秒前
苹果紫完成签到 ,获得积分10
18秒前
深情安青的应助被18756828852采纳,获得30
19秒前
嘻嘻哈哈的应助被江子川采纳,获得10
19秒前
ttchen的应助被江子川采纳,获得10
19秒前
完美世界的应助被江子川采纳,获得10
19秒前
复杂的方盒完成签到 ,获得积分10
19秒前
科研通AI6.2的应助被江子川采纳,获得10
19秒前
斯文败类的应助被江子川采纳,获得10
19秒前
科研通AI6.3的应助被江子川采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192871
求助须知:如何正确求助?哪些是违规求助? 9579281
关于积分的说明 21864358
捐赠科研通 7792445
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483928